Oral compositions

An oral composition, comprising:

• a) from about 0.001% to about 25% of at least one phosphate derivative having the structure:
• ##STR5## wherein R is a flavorant component selected from the group consisting of hexanol, octanol, decanol, geranolol, ethyl maltol, para-hydroxy phenylbutanone, phenyl ethyl alcohol, thymol, eugenol, eucalyptol, methyl salicylate, ethyl vanillin, vanillin, cinnamaldehyde glycerol acetal ("CGA"), or linalool;
• wherein R' and R" are independently selected from the group consisting of R, an adherent component, M.sup.+, M.sup.++, C.sup.+, and hydrogen;
• wherein X, X', X" are independently selected from the group consisting of oxygen, nitrogen, and sulfur;
• wherein n is an integer from 1 to 3;
• b) a safe and effective amount of a copper ion source;
• and
• c) an pharmaceutically acceptable oral carrier.